InvestmentJun 22, 2026, 04:02 PM
RedHill Biopharma Raises $6M in Private Placement
AI Summary
RedHill Biopharma Ltd. has entered into a private placement agreement with an accredited investor to issue 8,571,429 American Depositary Shares (ADSs) and accompanying Series A-1 and Series A-2 warrants. The combined purchase price is $0.70 per ADS and warrants. The company expects to raise approximately $6 million in gross proceeds from this offering, with a potential additional $13.4 million if all warrants are exercised. H.C. Wainwright & Co. acted as the exclusive placement agent.
Key Highlights
- RedHill Biopharma entered a private placement with an accredited investor.
- The offering includes 8,571,429 American Depositary Shares (ADSs) and warrants.
- Combined purchase price is $0.70 per ADS and accompanying warrants.
- Expected gross proceeds from the offering are approximately $6 million.
- Potential additional gross proceeds from warrant exercises are approximately $13.4 million.
- Series A-1 warrants have an exercise price of $0.86 per ADS and a 5-year term.
- Series A-2 warrants have an exercise price of $0.70 per ADS and an 18-month term.
- H.C. Wainwright & Co. received a 7.5% cash fee and warrants for 514,286 ADSs.
Price Impact
More from RDHL